Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world
Authors
Keywords
Advanced gastric cancer, Second-line chemotherapy, Prognostic factors, Overall survival, Progression-free survival
Journal
Gastric Cancer
Volume 20, Issue 5, Pages 825-833
Publisher
Springer Nature
Online
2016-12-27
DOI
10.1007/s10120-016-0681-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction and oesophageal adenocarcinoma: a meta-analysis of patient-level data
- (2016) Tobias Janowitz et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical impact of tumour biology in the management of gastroesophageal cancer
- (2016) Florian Lordick et al. Nature Reviews Clinical Oncology
- Update on Metastatic Gastric and Esophageal Cancers
- (2015) Manish A. Shah JOURNAL OF CLINICAL ONCOLOGY
- Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis
- (2014) Nicola Silvestris et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey
- (2014) Giuseppe Aprile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis
- (2013) H. S. Kim et al. ANNALS OF ONCOLOGY
- Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial
- (2013) Shuichi Hironaka et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
- (2013) Hugo E R Ford et al. LANCET ONCOLOGY
- A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy
- (2010) D. Kanagavel et al. ANNALS OF ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
- (2009) Kenji Hashimoto et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
- (2008) V Catalano et al. BRITISH JOURNAL OF CANCER
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation